Bristol Myers Squibb logo

Associate Director, WW Medical Learning, Neuro

Bristol Myers Squibb

Princeton, NJHybridPosted 40 days ago$177,990 - $215,682/year
Full TimeDirector & AboveMedical AffairsPharmaceutical
Original posting ↗

Summary

WW Medical Learning is seeking a strategic leader to own the scientific learning agenda for BMS Neurology across WW/International Markets. This is predominantly a strategy-setting role: the Associate Director defines what FM and HOM teams globally need to know and be able to do in order to deliver trusted, high-impact scientific exchange – and builds the multi-year plans, partnerships, and governance model that make that possible.

Job description

Strategic Remit & Key Relationships

Reporting to the Director, WW/International Markets Medical Learning, this role holds an enterprise-wide view of the training needs of WW/International Markets FM and HOM teams and is accountable for shaping how those needs are met in partnership with WW Medical Learning and WW Commercialisation Learning. Success depends on building and governing senior-level relationships across WW Medical Affairs, International Markets Medical Enablement, the WW Commercialisation Learning Centre of Excellence, Medical Excellence, and US Medical Learning – aligning investment, content strategy, and delivery models with the strategic priorities of the WW medical matrix. This is a home office-based role with the ability to travel (up to ~10% based on requirements).

Strategic Accountabilities

  • Own the multi-year scientific learning strategy for WW/International Markets neurology translating medical and commercial priorities into a coherent roadmap that governs how FM and HOM capability is built and sustained.
  • Set the strategic framework for launch readiness, defining the standards, milestones, and governance that ensure FM and HOM teams globally are positioned to support priority clinical trials and major data readouts ahead of need.
  • Architect the WW Medical learning approach to scientific data education at major medical congresses – establishing the strategic model for embargoed data readiness, post-congress contextualization, and knowledge-retention systems adopted across international markets.
  • Build and govern a strategic partnership model across WW Medical Affairs, US Medical Learning, the WW Commercialisation Learning Centre of Excellence, Medical Excellence, and International Markets Medical Enablement teams, ensuring learning investment is concentrated against the highest-impact business priorities and content is leveraged rather than duplicated.
  • Champion innovation and AI, in scientific education, evaluating and introducing new learning modalities, technologies, and adult-learning methodologies that raise the bar for the broader WW Medical Learning function.
  • Define the strategic model for scientific onboarding and continuous learning journeys for international FM/HOM teams – ensuring consistency, scalability, and reuse of content developed for first market launches across subsequent worldwide launches.
  • Set the strategy for measuring learning effectiveness, using training needs assessments and stakeholder feedback to shape where the function invests next, and advising the Director, WW/International Markets Medical Learning accordingly.
  • Act as a strategic business partner with senior HOM and FM leadership to establish governance around training cadence – protecting field capacity for core activities while ensuring the organisation remains scientifically ready.
  • Collaborate with International Market Medical Enablement team for deployment of scientific/skills resources
  • Work closely with US Medical Learning and International Market Medical Enablement teams to support strategic alignment in education plans and resource development, leveraging and modifying content developed in support of first market launches for subsequent market launches for worldwide usage.
  • Direct resourcing and vendor strategy for the therapeutic area, ensuring third-party support is deployed against the highest-priority strategic initiatives.
  • Align all trainings with medical strategic imperatives, medical communication topics, scientific narratives, and core competencies
  • Act as a thought partner and advisor to the Director on the overall prioritisation, and evolution of the WW/International Markets Medical Learning portfolio.
  • Create annual WW training plans based on training needs assessments to support the needs of HOM and FM teams; work with matrix partners to align plans with strategic needs of the business (WW Medical Affairs, US Scientific Learning, Medical Excellence, etc)
  • Consistently evaluate quality of training materials & programs and medical training needs by regularly conducting training needs assessments with the Director, WW/International Market Medical Learning
  • Demonstrate flexibility during times of competing priorities & participate in training of new team hires as appropriate

Qualifications

  • Advanced degree required: MD, DO, PharmD, DNP, PhD, or MSN strongly preferred
  • 2+ years TA experience preferred
  • 5+ years pharmaceutical / biotech / relevant industry experience as a field MSL or similar field-based and/or office-based position preferred with a proven track record of success
  • Proven ability to set direction and influence senior stakeholders across matrixed, global organisations without direct authority.
  • Strong executive presence and public presentation skills, with the ability to represent a strategic agenda to senior leadership.
  • Demonstrated strategic planning, prioritisation, and portfolio-management skills across competing priorities and tight timelines.
  • Deep knowledge and applied expertise in adult learning principles and the design of effective, scalable learning solutions.
  • Excellent written, verbal, and interpersonal communication skills, with the ability to build and sustain senior internal and external partnerships.
  • A self-directed, highly motivated individual comfortable operating with minimal direction and high accountability for outcomes.
  • Ability to travel (up to ~10% based on requirements).

Requirements

  • Advanced degree required: MD, DO, PharmD, DNP, PhD, or MSN strongly preferred
  • 2+ years TA experience preferred
  • 5+ years pharmaceutical / biotech / relevant industry experience as a field MSL or similar field-based and/or office-based position preferred
  • Proven ability to set direction and influence senior stakeholders across matrixed, global organisations without direct authority
  • Strong executive presence and public presentation skills
  • Demonstrated strategic planning, prioritisation, and portfolio-management skills
  • Deep knowledge and applied expertise in adult learning principles and scalable learning solutions
  • Excellent written, verbal, and interpersonal communication skills
  • Self-directed, highly motivated, comfortable operating with minimal direction
  • Ability to travel up to ~10%

Benefits

  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Retirement Benefits
  • Financial Protection Benefits
  • Flexible Time Off
  • 11 Paid Company Holidays
  • Paid Sick Leave
  • Volunteer Days
  • Summer Hours Flexibility
  • Global Shutdown

Company overview

Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.